Advisory Board 

Provectus Therapeutics has diverse advisory board members from different professional backgrounds, including Biomedical Engineering, Medical Oncology, Computer Science and Entrepreneurship. 

Prof. John MOK
Chairman, AML Holdings Limited
Founding Chairman, HK Medical & Healthcare Device Industries Association

Startup Mentor

Prof. John Mok has over 40 years solid experience in engineering & manufacturing of electronics and biomedical products.

He led AML Group in setting up Corporate University and in winning Innovative Technology Achievement Award, Corporate Social Responsibility Award, Mold & Die Award and several HK Industries Awards in Quality, Productivity & Machine Design.


Prof. Li Yu
Assistant Professor, Department of Computer Science, CUHK

Artificial Intelligence Advisor

Prof. Li works as an assistant professor, Department of Computer Science, CUHK with outstanding contribution in implementing Artificial Intelligence to encounter computational problems in biology and healthcare. 


Dr. Jemma Arakelyan, M.D.

Medical Oncology Advisor

Dr Arakelyan is a medical oncologist who graduated from Yerevan State Medical University and Harvard Medical School. Dr Arakelyan has rich experience in actual practice on chemotherapy treatment for cancer patients, oncology research and drug discovery. She is determined and passionate about improving current treatment for cancer patients.


Mr Francesco Stadler
Director of Impact Funds & Ventures, Sustainable Finance Initiative

Entrepreneurship Advisor

Over 10 years of experience in the financial industry, of which 7 years in sustainable investing. Focus on PE, VC, venture investments. Certified ESG Analyst (CESGA®) and sustainability expert (GRI and UNPRI).


Collaborator

To accelerate the development of precision medicine in oncology,
we are open to collaborate with research experts from different industries.

Prof. Gary Tse
MBBS, FRCPC, FCAP, DAB(AP), FRCPath, MIAC


Chairman and Professor, Department of Anatomical and Cellular Pathology, PWH

Prof. Tse is the Chairman and Professor in the Department of Anatomical and Cellular Pathology, Prince of Wales Hosiptal. Prof. Tse is a histopathologist with active interests in breast pathology, various prognostic factors in breast cancers, molecular classification of breast disease, and molecular basis in morphological features.